NIH Funding Opportunities and Notices for The Week Ending03-13-2020

Notice of Change to salary allowance for K00 awardees for NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)
(NOT-NS-20-040)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research

Notice of Change to Key Dates for PA-18-358 "NINDS Exploratory Neuroscience Research Grant (R21 - Clinical Trial Optional)"
(NOT-NS-20-042)
National Institute of Neurological Disorders and Stroke

Notices of Special Interest

Notice of Special Interest: Digital Technology for Early Detection of Alzheimers Disease and Related Dementias
(NOT-AG-20-017)
National Institute on Aging

Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD)
(NOT-CA-20-031)
National Cancer Institute
National Institute of Dental and Craniofacial Research

Notice of Special Interest: Administrative Supplements to Support Resource Hubs to Promote Multi-Sectoral Rural Health Disparities Research
(NOT-MD-20-010)
National Institute on Minority Health and Health Disparities

Notice of Special Interest for HEAL Initiative: Request for Administrative Supplements to Existing Grants for Identification and Validation of New Pain and Opioid Use Disorder Targets within the Understudied Druggable Genome
(NOT-TR-20-008)
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke

Funding Opportunities

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
(PA-20-135)
National Institutes of Health
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Human Genome Research Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute on Minority Health and Health Disparities
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): See the Emergency Notice of Special Interest (NOSI) for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
(PAR-20-131)
National Cancer Institute
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 05, 2020
Development and Maintenance of the Animal Feed Regulatory Program Standards with Optional Coordinated Preventive Control Regulatory Activities and Capacity Building (U18) Clinical Trial Not Allowed
(PAR-20-132)
Food and Drug Administration
Application Receipt Date(s): May 13, 2020 by 11:59 PM Eastern Time. February 15, 2021 by 11:59 PM Eastern Time. February 15, 2022, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)
(PAR-20-133)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Application Receipt Date(s): June 18, 2020; June 8, 2021
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)
(PAR-20-134)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Application Receipt Date(s): June 18, 2020; June 08, 2021
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
(PAR-20-136)
National Cancer Institute
Application Receipt Date(s): April 7, 2020; November 9, 2020; April 9, 2021; November 9, 2021; April 7, 2022; November 9, 2022
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
(PAR-20-137)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
Office of Research on Women's Health
Application Receipt Date(s): June 5, 2020 (new) and July 5, 2020 (renewal, resubmission, revision); October 5, 2020 (new) and November 5, 2020 (renewal, resubmission, revision); June 5, 2021 (new) and July 5, 2021 (renewal, resubmission, revision); October 5, 2021 (new) and November 5, 2021 (renewal, resubmission, revision); June 5, 2022 (new) and July 5, 2022 (renewal, resubmission, revision); October 5, 2022 (new) and November 5, 2022 (renewal, resubmission, revision)
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
(PAR-20-139)
National Institute of Allergy and Infectious Diseases
National Institute on Aging
Application Receipt Date(s): May 13, 2020; September 13, 2020; January 13, 2021; May 13, 2021; September 13, 2021; January 13, 2022; May 13, 2022; September 13, 2022; January 13, 2023
Artificial Intelligence and Technology Collaboratories for Aging Research (P30 Clinical Trial Optional)
(RFA-AG-21-009)
National Institute on Aging
Application Receipt Date(s): October 1, 2020. No late applications will be accepted for this funding opportunity announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Artificial Intelligence and Technology Collaboratories for Aging Research Coordinating Center (AITCC) (R24 Clinical Trial Not Allowed)
(RFA-AG-21-018)
National Institute on Aging
Application Receipt Date(s): October 1, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
Alzheimers Disease Research Centers (P30 Clinical Trial Not Allowed)
(RFA-AG-21-019)
National Institute on Aging
Application Receipt Date(s): September 15, 2020 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date.
Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-20-015)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
(RFA-AI-20-028)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): June 29, 2020
NIAMS Resource-based Centers for Bone, Muscle and Orthopaedic Research (BMOR) (P30 - Clinical Trials Not Allowed)
(RFA-AR-21-004)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): August 11, 2020, by 5:00 PM local time of applicant organization. All applications are due by 5:00 PM local time of applicant organization. All allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R01 Clinical Trial Not Allowed)
(RFA-DE-20-006)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 8 20 , 2020 No late applications will be accepted for this Funding Opportunity Announcement
Defining Lineage Plasticity and Endogenous Regeneration Capacity of Dental, Oral, and Craniofacial Tissues (R21 Clinical Trial Not Allowed)
(RFA-DE-20-007)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 8, 2020; No late applications will be accepted for this Funding Opportunity Announcement
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
(RFA-DK-20-006)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): July 22, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Retail Food Safety Association Collaboration (U18) Clinical Trial Not Allowed
(RFA-FD-20-028)
Food and Drug Administration
Application Receipt Date(s): May 13, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
(RFA-FD-20-030)
Food and Drug Administration
Application Receipt Date(s): May 11, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01) Clinical Trials Not Allowed
(RFA-FD-20-031)
Food and Drug Administration
Application Receipt Date(s): May 18, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Population Dynamics Centers Research Infrastructure Program FY 2021 (P2C Clinical Trial Not Allowed)
(RFA-HD-21-010)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Postdoctoral Training in Pediatric Clinical Pharmacology (T32 Clinical Trial Not Allowed)
(RFA-HD-21-014)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): May 27, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-HG-20-019)
National Human Genome Research Institute
Application Receipt Date(s): June 24, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (U24 Clinical Trial Optional)
(RFA-HL-21-007)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 8, 2020
Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)
(RFA-HL-21-008)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 8, 2020
Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
(RFA-HL-21-009)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 8, 2020